Apollo Endosurgery Stock Price, News & Analysis (NASDAQ:APEN)

$4.50 0.13 (2.97 %)
(As of 12/11/2017 08:13 AM ET)
Previous Close$4.37
Today's Range$4.28 - $4.66
52-Week Range$3.55 - $21.88
Volume51,700 shs
Average Volume100,692 shs
Market Capitalization$77.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.46

About Apollo Endosurgery (NASDAQ:APEN)

Apollo Endosurgery logoApollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company's products include ORBERA, LAP-BAND and OverStitch. The Company's product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.

Receive APEN News and Ratings via Email

Sign-up to receive the latest news and ratings for APEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:APEN
CUSIPN/A
Phone512-279-5100

Debt

Debt-to-Equity Ratio0.58%
Current Ratio2.54%
Quick Ratio2.00%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$64.87 million
Price / Sales1.20
Cash FlowN/A
Price / CashN/A
Book Value$3.96 per share
Price / Book1.14

Profitability

Trailing EPS($36.74)
Net Income$-41,160,000.00
Net Margins-62.31%
Return on Equity-98.11%
Return on Assets-40.61%

Miscellaneous

Employees193
Outstanding Shares17,290,000

Apollo Endosurgery (NASDAQ:APEN) Frequently Asked Questions

What is Apollo Endosurgery's stock symbol?

Apollo Endosurgery trades on the NASDAQ under the ticker symbol "APEN."

Where is Apollo Endosurgery's stock going? Where will Apollo Endosurgery's stock price be in 2017?

3 brokers have issued 1-year target prices for Apollo Endosurgery's shares. Their predictions range from $10.00 to $12.00. On average, they expect Apollo Endosurgery's stock price to reach $11.00 in the next year. View Analyst Ratings for Apollo Endosurgery.

What are Wall Street analysts saying about Apollo Endosurgery stock?

Here are some recent quotes from research analysts about Apollo Endosurgery stock:

  • 1. Northland Securities analysts commented, "We highlight an interesting effort being undertaken by Apollo to evaluate possibility of reimbursement" for the Orbera IGB, as a precursor to other major surgeries. Clinically, the proposition makes sense; the question really remains….how do we get reimbursement? Key Points IGB’ prior to Heart Transplant Surgery Obesity is a complicating comorbidity in many patients with advanced HF & consensus recommendations advise against cardiac transplantation in patients with HF and BMI > 35 kg/m2. Transplant eligibility requires weight loss, which is challenging, as exercise capability is often limited owing to diminished functional status (Source: http://www.jhltonline.org/article/ S1053-2498(15)01484-9/fulltext#s0035) As is well known, there are roughly 4,000 heart transplants in the U.S. every year. The concept of using an Orbera IGB prior to an actual heart transplant or LVAD surgery is intriguing." (12/4/2017)
  • 2. According to Zacks Investment Research, "Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas. " (11/2/2017)

Who are some of Apollo Endosurgery's key competitors?

Who owns Apollo Endosurgery stock?

Apollo Endosurgery's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Stonepine Capital Management LLC (13.68%), King Luther Capital Management Corp (3.17%), Russell Investments Group Ltd. (1.59%), Woodmont Investment Counsel LLC (0.27%) and JPMorgan Chase & Co. (0.15%). Company insiders that own Apollo Endosurgery stock include A/S Novo, Bret Schwartzhoff, Holdings A/S Novo, Richard J Meelia, Sciences L P Ptv II, Stefanie L Cavanaugh, Todd Newton and William D Jr Mcclellan. View Institutional Ownership Trends for Apollo Endosurgery.

Who bought Apollo Endosurgery stock? Who is buying Apollo Endosurgery stock?

Apollo Endosurgery's stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, King Luther Capital Management Corp, Russell Investments Group Ltd., Woodmont Investment Counsel LLC and JPMorgan Chase & Co.. Company insiders that have bought Apollo Endosurgery stock in the last two years include Bret Schwartzhoff, Richard J Meelia, Sciences L P Ptv II, Stefanie L Cavanaugh, Todd Newton and William D Jr Mcclellan. View Insider Buying and Selling for Apollo Endosurgery.

How do I buy Apollo Endosurgery stock?

Shares of Apollo Endosurgery can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Apollo Endosurgery's stock price today?

One share of Apollo Endosurgery stock can currently be purchased for approximately $4.50.

How big of a company is Apollo Endosurgery?

Apollo Endosurgery has a market capitalization of $77.81 million and generates $64.87 million in revenue each year. The biotechnology company earns $-41,160,000.00 in net income (profit) each year or ($36.74) on an earnings per share basis. Apollo Endosurgery employs 193 workers across the globe.

How can I contact Apollo Endosurgery?

Apollo Endosurgery's mailing address is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. The biotechnology company can be reached via phone at 512-279-5100 or via email at [email protected]


MarketBeat Community Rating for Apollo Endosurgery (APEN)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  122
MarketBeat's community ratings are surveys of what our community members think about Apollo Endosurgery and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Apollo Endosurgery (NASDAQ:APEN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.86$8.86$7.82$2.45
Price Target Upside: 96.51% upside107.14% upside25.87% upside4.70% upside

Apollo Endosurgery (NASDAQ:APEN) Consensus Price Target History

Price Target History for Apollo Endosurgery (NASDAQ:APEN)

Apollo Endosurgery (NASDAQ:APEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2017Northland SecuritiesReiterated RatingBuy$12.00LowView Rating Details
8/2/2017Roth CapitalInitiated CoverageBuy -> Buy$10.00MediumView Rating Details
7/24/2017Craig HallumInitiated CoverageBuy$11.00HighView Rating Details
8/19/2016S&P Equity ResearchLower Price Target$3.15 -> $2.45N/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Apollo Endosurgery (NASDAQ:APEN) Earnings History and Estimates Chart

Earnings by Quarter for Apollo Endosurgery (NASDAQ:APEN)

Apollo Endosurgery (NASDAQ APEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017Q2 2017($0.24)($0.64)$17.14 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.77)$14.62 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Apollo Endosurgery (NASDAQ:APEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.98 EPS
Next Year EPS Consensus Estimate: $-1.18 EPS

Dividends

Dividend History for Apollo Endosurgery (NASDAQ:APEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Apollo Endosurgery (NASDAQ APEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 74.20%
Institutional Ownership Percentage: 23.67%
Insider Trades by Quarter for Apollo Endosurgery (NASDAQ:APEN)
Institutional Ownership by Quarter for Apollo Endosurgery (NASDAQ:APEN)

Apollo Endosurgery (NASDAQ APEN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/7/2017Bret SchwartzhoffVPBuy9,500$4.24$40,280.00View SEC Filing  
7/26/2017Holdings A/S NovoMajor ShareholderSell50,130$6.90$345,897.00View SEC Filing  
7/25/2017Richard J MeeliaDirectorBuy45,454$5.50$249,997.00View SEC Filing  
7/25/2017Sciences L P Ptv IIMajor ShareholderBuy1,090,909$5.50$5,999,999.50View SEC Filing  
7/25/2017Stefanie L CavanaughCFOBuy4,545$5.50$24,997.50View SEC Filing  
7/25/2017Todd NewtonCEOBuy136,363$5.50$749,996.50View SEC Filing  
5/18/2017Todd NewtonCEOBuy2,121$6.22$13,192.62View SEC Filing  
5/17/2017William D Jr. McclellanDirectorBuy2,000$6.33$12,660.00View SEC Filing  
5/11/2017A/S NovoMajor ShareholderSell105,000$5.63$591,150.00View SEC Filing  
12/12/2014Daniel H PetreeDirectorBuy10,000$2.79$27,900.00View SEC Filing  
8/20/2014Gary J G AtkinsonCFOBuy5,000$3.10$15,500.00View SEC Filing  
8/19/2014Scott R PancoastCEOBuy10,000$3.00$30,000.00View SEC Filing  
8/18/2014Scott R PancoastCEOBuy10,000$3.22$32,200.00View SEC Filing  
12/19/2012Charles MathewsDirectorBuy5,000$4.98$24,900.00View SEC Filing  
12/18/2012Scott R PancoastCEOBuy5,000$4.95$24,750.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Apollo Endosurgery (NASDAQ APEN) News Headlines

Source:
DateHeadline
Zacks: Brokerages Anticipate Apollo Endosurgery, Inc. (APEN) Will Post Earnings of -$0.33 Per ShareZacks: Brokerages Anticipate Apollo Endosurgery, Inc. (APEN) Will Post Earnings of -$0.33 Per Share
www.americanbankingnews.com - December 10 at 11:32 PM
Apollo Endosurgery (APEN) Rating Reiterated by Northland SecuritiesApollo Endosurgery (APEN) Rating Reiterated by Northland Securities
www.americanbankingnews.com - December 4 at 11:38 AM
Apollo Endosurgery Inc. (APEN) Leaped After FDA ClearanceApollo Endosurgery Inc. (APEN) Leaped After FDA Clearance
www.rttnews.com - November 30 at 4:15 PM
Northland Securities Reaffirms "Buy" Rating for Apollo Endosurgery (APEN)Northland Securities Reaffirms "Buy" Rating for Apollo Endosurgery (APEN)
www.americanbankingnews.com - November 29 at 1:48 PM
Apollo Endosurgery (APEN) Announces FDA Clearance for OverStitch Sx Endoscopic Suturing SystemApollo Endosurgery (APEN) Announces FDA Clearance for OverStitch Sx Endoscopic Suturing System
www.streetinsider.com - November 28 at 11:43 AM
Apollo Endosurgerys stock rockets on FDA clearance of OverStitch SxApollo Endosurgery's stock rockets on FDA clearance of OverStitch Sx
www.marketwatch.com - November 28 at 11:43 AM
Apollo Endosurgery Inc. (APEN) Is Surging After Receiving FDA ClearanceApollo Endosurgery Inc. (APEN) Is Surging After Receiving FDA Clearance
www.rttnews.com - November 28 at 11:43 AM
Apollo Endosurgery Surges on FDA ApprovalApollo Endosurgery Surges on FDA Approval
247wallst.com - November 28 at 11:43 AM
Apollo Endosurgery Inc (APEN) Sparks Optimism Among Investors; Here’s WhyApollo Endosurgery Inc (APEN) Sparks Optimism Among Investors; Here’s Why
finance.yahoo.com - November 28 at 11:43 AM
Apollo Endosurgery Receives FDA Clearance for OverStitch™ Sx Endoscopic Suturing SystemApollo Endosurgery Receives FDA Clearance for OverStitch™ Sx Endoscopic Suturing System
finance.yahoo.com - November 28 at 11:43 AM
$16.65 Million in Sales Expected for Apollo Endosurgery, Inc. (APEN) This Quarter$16.65 Million in Sales Expected for Apollo Endosurgery, Inc. (APEN) This Quarter
www.americanbankingnews.com - November 25 at 11:54 AM
 Apollo Endosurgery, Inc. (APEN) Given Average Rating of "Strong Buy" by Analysts Apollo Endosurgery, Inc. (APEN) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 23 at 3:10 AM
 Analysts Anticipate Apollo Endosurgery, Inc. (APEN) to Post -$0.29 EPS Analysts Anticipate Apollo Endosurgery, Inc. (APEN) to Post -$0.29 EPS
www.americanbankingnews.com - November 23 at 1:28 AM
Zacks: Apollo Endosurgery, Inc. (APEN) Given $11.50 Consensus Target Price by AnalystsZacks: Apollo Endosurgery, Inc. (APEN) Given $11.50 Consensus Target Price by Analysts
www.americanbankingnews.com - November 19 at 7:12 AM
Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare ConferenceApollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 17 at 8:44 PM
David C. Pacitti Joins Apollo Endosurgery Board of DirectorsDavid C. Pacitti Joins Apollo Endosurgery Board of Directors
finance.yahoo.com - November 16 at 9:13 PM
Insider Buying: Apollo Endosurgery, Inc. (APEN) VP Purchases 9,500 Shares of StockInsider Buying: Apollo Endosurgery, Inc. (APEN) VP Purchases 9,500 Shares of Stock
www.americanbankingnews.com - November 10 at 12:40 AM
Apollo Endosurgery, Inc. (APEN) Expected to Announce Quarterly Sales of $16.65 MillionApollo Endosurgery, Inc. (APEN) Expected to Announce Quarterly Sales of $16.65 Million
www.americanbankingnews.com - November 5 at 4:08 AM
Zacks: Analysts Expect Apollo Endosurgery Inc (APEN) Will Announce Earnings of -$0.29 Per ShareZacks: Analysts Expect Apollo Endosurgery Inc (APEN) Will Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - November 3 at 11:19 PM
Analyzing Apollo Endosurgery (APEN) and Tactile Systems Technology (TCMD)Analyzing Apollo Endosurgery (APEN) and Tactile Systems Technology (TCMD)
www.americanbankingnews.com - November 3 at 3:18 AM
Apollo Endosurgery, Inc. (APEN) Lifted to Buy at Zacks Investment ResearchApollo Endosurgery, Inc. (APEN) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - November 2 at 8:33 PM
Apollo Endosurgery, Inc. :APEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Apollo Endosurgery, Inc. :APEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 4:28 PM
Tactile Systems Technology (TCMD) versus Apollo Endosurgery (APEN) Head-To-Head SurveyTactile Systems Technology (TCMD) versus Apollo Endosurgery (APEN) Head-To-Head Survey
www.americanbankingnews.com - November 1 at 1:08 PM
Apollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeekApollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeek
finance.yahoo.com - October 30 at 4:54 PM
Apollo Endosurgery (APEN) Tops Q3 EPS by 8c, Slight Miss on RevenuesApollo Endosurgery (APEN) Tops Q3 EPS by 8c, Slight Miss on Revenues
www.streetinsider.com - October 28 at 4:11 AM
Penumbra (PEN) and Apollo Endosurgery (APEN) Financial ContrastPenumbra (PEN) and Apollo Endosurgery (APEN) Financial Contrast
www.americanbankingnews.com - October 27 at 9:20 PM
Apollo Endosurgery, Inc. (APEN) Earns Buy Rating from Northland SecuritiesApollo Endosurgery, Inc. (APEN) Earns Buy Rating from Northland Securities
www.americanbankingnews.com - October 27 at 2:26 PM
Apollo Endosurgery beats by $0.08, misses on revenueApollo Endosurgery beats by $0.08, misses on revenue
seekingalpha.com - October 26 at 8:59 PM
Apollo Endosurgery, Inc. Reports Third Quarter 2017 ResultsApollo Endosurgery, Inc. Reports Third Quarter 2017 Results
finance.yahoo.com - October 26 at 8:59 PM
Apollo Endosurgery and American Gastroenterological Association to Establish Endoscopic Suturing Procedure RegistryApollo Endosurgery and American Gastroenterological Association to Establish Endoscopic Suturing Procedure Registry
finance.yahoo.com - October 24 at 10:41 PM
Apollo Endosurgery to Report Third Quarter 2017 Financial Results on October 26, 2017Apollo Endosurgery to Report Third Quarter 2017 Financial Results on October 26, 2017
finance.yahoo.com - October 19 at 4:29 PM
Head-To-Head Comparison: Apollo Endosurgery (APEN) versus iRadimed Corporation (IRMD)Head-To-Head Comparison: Apollo Endosurgery (APEN) versus iRadimed Corporation (IRMD)
www.americanbankingnews.com - October 19 at 11:33 AM
Analyzing Apollo Endosurgery (APEN) and Penumbra (PEN)Analyzing Apollo Endosurgery (APEN) and Penumbra (PEN)
www.americanbankingnews.com - October 17 at 6:24 PM
$16.64 Million in Sales Expected for Apollo Endosurgery, Inc. (APEN) This Quarter$16.64 Million in Sales Expected for Apollo Endosurgery, Inc. (APEN) This Quarter
www.americanbankingnews.com - October 17 at 8:12 AM
 Analysts Expect Apollo Endosurgery, Inc. (APEN) Will Announce Earnings of -$0.40 Per Share Analysts Expect Apollo Endosurgery, Inc. (APEN) Will Announce Earnings of -$0.40 Per Share
www.americanbankingnews.com - October 15 at 8:30 AM
Financial Review: Apollo Endosurgery (APEN) vs. iRadimed Corporation (IRMD)Financial Review: Apollo Endosurgery (APEN) vs. iRadimed Corporation (IRMD)
www.americanbankingnews.com - October 13 at 2:26 PM
Reviewing Apollo Endosurgery (APEN) & Tactile Systems Technology (TCMD)Reviewing Apollo Endosurgery (APEN) & Tactile Systems Technology (TCMD)
www.americanbankingnews.com - October 13 at 12:15 PM
Comparing Penumbra (PEN) and Apollo Endosurgery (APEN)Comparing Penumbra (PEN) and Apollo Endosurgery (APEN)
www.americanbankingnews.com - October 13 at 4:28 AM
Financial Contrast: Penumbra (PEN) & Apollo Endosurgery (APEN)Financial Contrast: Penumbra (PEN) & Apollo Endosurgery (APEN)
www.americanbankingnews.com - October 11 at 2:22 PM
Reviewing iRadimed Corporation (IRMD) & Apollo Endosurgery (APEN)Reviewing iRadimed Corporation (IRMD) & Apollo Endosurgery (APEN)
www.americanbankingnews.com - October 9 at 10:12 AM
Contrasting Apollo Endosurgery (APEN) and Tactile Systems Technology (TCMD)Contrasting Apollo Endosurgery (APEN) and Tactile Systems Technology (TCMD)
www.americanbankingnews.com - October 8 at 4:34 AM
Apollo Endosurgery, Inc. :APEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Apollo Endosurgery, Inc. :APEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 4:13 PM
Apollo Endosurgery, Inc. (APEN) Receives New Coverage from Analysts at Northland SecuritiesApollo Endosurgery, Inc. (APEN) Receives New Coverage from Analysts at Northland Securities
www.americanbankingnews.com - October 2 at 12:10 AM
Analyzing Apollo Endosurgery (APEN) & Masimo Corporation (MASI)Analyzing Apollo Endosurgery (APEN) & Masimo Corporation (MASI)
www.americanbankingnews.com - September 29 at 10:10 PM
Apollo Endosurgery (APEN) Presents At Cantor Fitzgerald Global Healthcare Conference - SlideshowApollo Endosurgery (APEN) Presents At Cantor Fitzgerald Global Healthcare Conference - Slideshow
seekingalpha.com - September 28 at 1:04 AM
Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare ConferenceApollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 19 at 8:58 PM
Apollo Endosurgery Announces 20-year LAP-BAND® Outcomes Data Presented at 22nd IFSO World Congress in LondonApollo Endosurgery Announces 20-year LAP-BAND® Outcomes Data Presented at 22nd IFSO World Congress in London
finance.yahoo.com - August 31 at 8:50 PM
Apollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon ...Apollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon ...
www.businesswire.com - August 30 at 5:08 PM
Apollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category LeaderApollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category Leader
finance.yahoo.com - August 30 at 5:08 PM
Apollo Endosurgery Provides Update and Clarity to FDA Letter to Health Care Providers Related to Potential Risks of Intragastric BalloonsApollo Endosurgery Provides Update and Clarity to FDA Letter to Health Care Providers Related to Potential Risks of Intragastric Balloons
finance.yahoo.com - August 11 at 3:31 AM

SEC Filings

Apollo Endosurgery (NASDAQ:APEN) SEC Filings

DateFilerForm TypeView
12/04/2017
3:25 PM
Apollo Endosurgery (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
11/30/2017
7:56 PM
Apollo Endosurgery (Subject)
PTV SCIENCES II L P (Filed by)
Form SC 13D/A
View Filing
11/30/2017
3:56 PM
Apollo Endosurgery (Issuer)
Pinto Technology Ventures GP II, L.P. (Reporting)
Pinto TV GP CO LLC (Reporting)
PTV Evergreen Fund, L.P. (Reporting)
PTV GP Evergreen, L.P. (Reporting)
PTV GP III Management, LLC (Reporting)
PTV GP IV, L.P. (Reporting)
PTV GP SO I, L.P. (Reporting)
PTV IV, L.P. (Reporting)
PTV SCIENCES II L P (Reporting)
PTV Special Opportunities I, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2017
3:55 PM
Anderson Rick D (Reporting)
Apollo Endosurgery (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2017
3:55 PM
Apollo Endosurgery (Issuer)
Crawford Matthew S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing

Social Media

Financials

Apollo Endosurgery (NASDAQ:APEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Apollo Endosurgery (NASDAQ APEN) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.